BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34257422)

  • 1. Increased risk for dementia in neurofibromatosis type 1.
    Kallionpää RA; Valtanen M; Auranen K; Uusitalo E; Rinne JO; Peltonen S; Peltonen J
    Genet Med; 2021 Nov; 23(11):2219-2222. PubMed ID: 34257422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
    Loponen N; Ylä-Outinen H; Kallionpää RA; Valtanen M; Auranen K; Järveläinen H; Peltonen S; Peltonen J
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2346. PubMed ID: 38131619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of neurofibromatosis type 1 in the Finnish population.
    Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
    Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland.
    Kallionpää RA; Johansson E; Böckerman P; Peltonen J; Peltonen S
    Eur J Hum Genet; 2024 Jan; 32(1):83-90. PubMed ID: 37460655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
    Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
    J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.
    Kurtelius A; Kallionpää RA; Huttunen J; Huttunen TJ; Helin K; Koivisto T; Frösen J; von Und Zu Fraunberg M; Peltonen S; Peltonen J; Jääskeläinen JE; Lindgren AE
    PLoS One; 2017; 12(6):e0178711. PubMed ID: 28575128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.
    Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Timonen S; Peltonen J; Peltonen S
    Am J Med Genet A; 2017 Oct; 173(10):2641-2648. PubMed ID: 28815922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
    Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
    Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
    Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
    Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
    Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
    J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland.
    Johansson E; Kallionpää RA; Böckerman P; Peltonen S; Peltonen J
    Genet Med; 2022 Apr; 24(4):870-879. PubMed ID: 34955382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
    Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
    Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.
    Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
    Orphanet J Rare Dis; 2018 Jan; 13(1):5. PubMed ID: 29335026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span.
    Kenborg L; Duun-Henriksen AK; Dalton SO; Bidstrup PE; Doser K; Rugbjerg K; Pedersen C; Krøyer A; Johansen C; Andersen KK; Østergaard JR; Hove H; Sørensen SA; Riccardi VM; Mulvihill JJ; Winther JF
    Genet Med; 2020 Jun; 22(6):1069-1078. PubMed ID: 32107470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of the
    Kallionpää RA; Peltonen S; Leppävirta J; Pöyhönen M; Auranen K; Järveläinen H; Peltonen J
    J Med Genet; 2021 Jun; 58(6):378-384. PubMed ID: 32571896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
    Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
    Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort.
    Lee SY; Lim JS; Oh DJ; Kong IG; Choi HG
    Medicine (Baltimore); 2019 Feb; 98(7):e14467. PubMed ID: 30762763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study.
    Kenborg L; Frederiksen LE; Galanakis M; Doser K; Nielsen TT; Doherty MA; Hove H; Østergaard JR; Handrup MM; Ejerskov C; Mulvihill JJ; Winther JF
    Orphanet J Rare Dis; 2023 Nov; 18(1):346. PubMed ID: 37932779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.